Table 3 Distribution pattern of quality of life (QOL) and health-status in clinical parameters of study population
Characteristics | Control (n = 199) | Arm 1 (n = 204) | Arm 2 (n = 197) | ARM 1 vs 2 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
QOL | Health status | QOL | Health status | p ł | QOL | Health status | p ł | p-value | |||||||
Mean | p-sig | Mean | p-sig | Mean | p-sig | Mean | p-sig | Mean | p-sig | Mean | p-sig | ||||
Duration of diabetes years | |||||||||||||||
0–5 | 7.81 | 0.00 | 75.70 | 0.00 | 8.71 | 0.02 | 72.14 | 0.02 | 0.01# | 8.98 | 0.01 | 73.45 | 0.00 | 0.02# | 0.86# |
6–10 | 9.61 | 70.51 | 10.63 | 70.11 | 0.78≠ | 10.88 | 69.45 | 0.04≠ | 0.74≠ | ||||||
> 10 | 10.88 | 64.89 | 10.71 | 63.80 | 10.91 | 61.89 | |||||||||
BMI (kg/m2) | |||||||||||||||
< 18.5/underweight | 7.75 | 0.01 | 75.25 | 0.00 | 8.85 | 0.74 | 69.28 | 0.86 | 0.03# | 10.03 | 0.78 | 71.04 | 0.52 | 0.01# | 0.44# |
18.5–24.9/healthy | 8.29 | 69.45 | 9.12 | 70.14 | 0.01≠ | 9.89 | 70.34 | 0.01≠ | 0.68≠ | ||||||
25.0–29.9/overweight | 9.48 | 65.14 | 9.58 | 69.85 | 10.18 | 69.25 | |||||||||
Comorbidities | |||||||||||||||
Congestive heart failure | 9.23 | 0.00 | 65.18 | 0.00 | 9.48 | 0.00 | 69.88 | 0.45 | 0.76# | 8.98 | 0.44 | 66.34 | 0.48 | 0.72# | 0.61# |
Hyperlipidemia | 7.48 | 64.89 | 7.37 | 70.45 | 0.01≠ | 6.98 | 65.62 | 0.01≠ | 0.04≠ | ||||||
Other minors | 7.19 | 70.09 | 7.88 | 70.19 | 7.21 | 69.45 | |||||||||
None | 6.81 | 75.10 | 7.01 | 70.23 | 7.42 | 68.61 | |||||||||
Treatment | |||||||||||||||
Oral glycemic agent | 10.49 | 0.04 | 70.15 | 0.00 | 10.09 | 0.02 | 69.39 | 0.47 | 0.71# | 10.40 | 0.54 | 69.25 | 0.21 | 0.71# | 0.63# |
Insulin | 9.27 | 70.84 | 9.16 | 67.45 | 0.01≠ | 8.76 | 68.34 | 0.01≠ | 0.25≠ | ||||||
Combination | 8.84 | 71.29 | 8.20 | 68.24 | 8.31 | 67.01 | |||||||||